Vensana Capital
Venture capitalMinneapolis · Series A–Late Stage · 12 people tracked
Also known as VENSANA CAPITAL MANAGEMENT, LLC
Investment thesis
Vensana Capital invests in development-stage and commercial-stage companies across the medtech sector, including medical devices, diagnostics and data science, drug delivery, digital health, life science tools, and tech-enabled services. The firm emphasizes partnering with experienced, insightful, and bold management teams, aiming to invest where its capital and commitment amplify the success of its entrepreneurs. Its focus is on backing companies pursuing transformative innovation in healthcare technology.
Source: firm website, verified Aug 25, 2026.
Team · 12 people
from public directories
What they invest in
from 29 of 32 portfolio companiesHealthtech ×24Medical Devices ×22Biotech ×14Digital Health ×6AI & Machine Learning ×5Hardware ×3Deep Tech ×2Data & Infrastructure ×1
HQs:United States×23Ireland×1
Investments · 32 tracked
founders shown can be your intro pathBy year:2026 · 22025 · 72024 · 22023 · 12022 · 22020 · 42019 · 119 dated
CVRx develops Barostim, an implantable medical device that uses baroreceptor activation to treat heart failure patients and improve their functional capacity and quality of life.
BiotechHealthtechMedical DevicesAustin, US
Craig Palmer(Executive Officer)Nadim Yared(Executive Officer, Director)Dean Bruhn-Ding(Executive Officer)John Brintnall(Executive Officer)Liz Galle(Executive Officer)
BoardGeoff Pardo(Director)
Board seatKirk Nielsen· per SEC Form D
Co-investorsNew Enterprise Associates (NEA)Treo Ventures, LlcWindham Capital PartnersYsios CapitalHatteras Venture Partners
BiotechGermantown, US
Mukul Jain(Executive Officer)Francine R. Kaufman(Executive Officer, Director)Rick Sullivan(Executive Officer)Kenneth L Horton(Executive Officer)Timothy T. Goodnow(Executive Officer, Director)Mirasol Panlilio(Executive Officer)
Board seatPeter Justin Klein· per SEC Form D · $30M raise · filed Sep 2020
Co-investorsNew Enterprise Associates (NEA)
SpyGlass Pharma develops a sustained drug delivery platform for treating chronic ophthalmic diseases such as glaucoma, integrating drugs, procedures, and devices for long-term disease control and vision preservation.
BiotechHealthtechMedical DevicesAliso Viejo, US
Malik Kahook(Executive Officer, Director)Glenn Sussman(Co-founder)inMalik Y. Kahook(Co-founder)Patrick Mooney(CEO)
BoardJake Merrill(Director)Geoff Pardo(Director)
Co-investorsNew Enterprise Associates (NEA)RA CapitalSamsara BioCapital
Nyra Medical develops the CARLEN (Cardiac Leaflet Enhancer) system, a transcatheter single-leaflet device for repairing functional mitral regurgitation while preserving native valve function.
BiotechHealthtechMedical DevicesAtlanta, US
Dr. Murali Padala(Founder)Dr. Eric Sarin(Founder, Director)Dr. Kirthana Suresh(Founder)Sai Muralidhar Padala(Executive Officer, Director)Murali Padala(Co-founder)Eric Sarin(Co-founder)
Co-investorsBroadview VenturesEpidarex CapitalGRA Venture
Vensana Innovation is a venture-backed startup studio ("innovation engine") that launches and builds medical technology companies, providing capital along with technical, clinical, commercial, and business development support at all stages from ideation to commercialization.
Deep TechHealthtechMedical Devices
Ben(Co-founder)Thomas Tu(CEO & Venture Partner)inBrian(Founding Member)Phil Marchand
Vesper Medical develops a modular venous stent portfolio designed to address the anatomical challenges of the iliac and femoral veins for treating deep venous disease.
HealthtechMedical DevicesWayne, US
Bruce J. Shook(President and CEO)Monica Klos(Executive Officer)Neil Hattangadi(Director)Peter Schneider(Director)Mark Garcia(Director)Dennis W. Wahr(Director)
Co-investorsNew Enterprise Associates (NEA)Gilde HealthcareLightstone Ventures415 Capital
Alleviant Medical develops an investigational minimally invasive medical device using interatrial shunt therapy to treat heart failure patients, currently in FDA-approved clinical trials (ALLAY-HF and ALLAY-HFrEF).
BiotechHealthtechMedical DevicesAustin, US
Adam Berman(Executive Officer, Director)Jacob Kriegel(Executive Officer, Director)Avni Patel(Executive Officer, Director)Christopher Alex Arevalos(Executive Officer, Director)Albertien Greijdanus(Executive Officer, Director)
BoardGeoff Pardo(Director)
Board seatKirk NielsenMaria Berkman· per SEC Form D
Co-investorsBroadview VenturesRiverVest Venture PartnersTMC Venture FundCadence Healthcare VenturesGilde HealthcareGilmartin Capital LLC+1 more
Artelon develops synthetic ligament and tendon reconstruction products based on its Dynamic Matrix technology for orthopedic soft tissue repair.
BiotechHealthtechMedical DevicesNew MaterialsMarietta, US
Lars Peterson(Founder)Aaron Smith(Executive Officer, Director)Mark Cohen(Director)Jeff Byrne(Executive Officer)Carter Meyer(Director)Steve Becker(Director)
Board seatKirk Nielsen· per SEC Form D
ChromaCode develops a High-Definition PCR (HDPCR) multiplexing platform that enables genomic solutions for oncology and precision medicine, offering faster results and cost-effective workflows through automated interpretation and cloud-based software.
AI & Machine LearningBiotechHealthtechMedical DevicesCarlsbad, US
Paul Flook(Executive Officer, Director)Gregory J. Gosch(Executive Officer, Director)Lynne Rollins(Executive Officer)Aditya Rajagopal(Director)Axel Scherer(Director)
Board seatJustin Klein· per SEC Form D
Co-investorsAdjuvant CapitalGlobal BrainMoore Venture PartnersNew Enterprise Associates (NEA)Windham Capital PartnersDomain Associates+2 more
Cleerly develops FDA-cleared, AI-driven analysis of noninvasive coronary CT (CCTA) imaging to characterize and quantify coronary artery disease.
AI & Machine LearningDigital HealthMedical DevicesDenver, US
James Min, MD(Founder)inJames K. Min(Executive Officer, Director)in
BoardLee Cooper(Director)Scott Barclay(Director)Louis Samson(Director)
Board seatPeter Justin Klein· per SEC Form D · $106.3M raise · filed Dec 2024
Co-investorsBattery VenturesBreyer CapitalInsight PartnersLRVHealthNew Leaf Venture Partners
IVEAcare develops neuromodulation and bioelectronics therapies, implantable medical devices aimed at treating chronic conditions for large patient populations.
Deep TechHealthtechMedical DevicesRoseville, US
Todd Kerkow(Co-Founder, President and CEO)inMudit Jain(Co-Founder and Chairman of the Board)Lynn(Co-Founder and Board Member)inCorey Dishmon(Director)Robert Greenberg(Director)
Board seatAmrinder SinghKirk Nielsen· per SEC Form D
Co-investorsTreo Ventures, LlcHatteras Venture Partners
Overnight automated insulin delivery
Wilmington, US
John Sjolund(Chief Executive Officer of the Issuer)Jon Brilliant(Chief Financial Officer of the Issuer)
BoardPeter N. Townsend(Director)
Board seatJustin KleinAmrinder Singh· per SEC Form D
Co-investorsSerpentine Ventures
Monteris develops minimally invasive laser ablation technology (LITT) used to treat brain conditions including oncology tumors and drug-resistant epilepsy.
BiotechHealthtechMedical DevicesPlymouth, US
JAMES ERICKSON(Executive Officer)MARTIN EMERSON(Executive Officer, Director)John Schellhorn(Executive Officer, Director, Promoter)Robert K Davidson(Executive Officer)Gregory Barrett(Director)Gary Bantle(Director)
Board seatKirk NielsenBill Hoffman· per SEC Form D · $13.7M raise · filed Sep 2022
Co-investorsThe Vertical Group
Okami Medical develops the LOBO vascular occlusion system, an occluder built on high-density, small-pore HDBRAID technology for fast arterial occlusion in the peripheral vasculature, along with SENDERO microcatheters and delivery catheters.
BiotechHardwareHealthtechMedical DevicesAliso Viejo, US
Brian J. Cox(Manager)Rhonda Robb(Executive Officer, Director)Robert Rosenbluth(Director)
BoardDonald Milder(Director)Jonathan Root(Director)inPaul Lubock(Director)
Board seatMike KramerKirk Nielsen· per SEC Form D
Co-investorsUS Venture PartnersGilde Healthcare
A precision oncology company providing genomic testing and resources to support cancer care decisions, operating under Labcorp Oncology.
BiotechDigital HealthHealthtechMedical DevicesBaltimore, US
Victor Velculescu(Executive Officer, Director, Promoter)Luis A. Diaz, Jr.(Executive Officer, Director, Promoter)Lisa Kann(Executive Officer)Sam Angiuoli(Executive Officer)Felix Dawson(Director)Anthony Newton(Executive Officer)
Board seatJustin Klein· per SEC Form D
Co-investors3B Future Health FundCatalio Capital Management, LPCo-Win VenturesNew Enterprise Associates (NEA)Windham Capital Partners
HealthtechBirmingham, US
Tom Livingston(Executive Officer, Director)Michael Jackson(Executive Officer)Robert E. Foster, M.D.(Executive Officer, Director)
BoardChase Wise(Director)
Board seatMike KramerKirk Nielsen· per SEC Form D · $21.7M raise · filed May 2025
Relievant offers the Intracept Procedure, a minimally invasive, FDA-cleared medical intervention designed to relieve chronic low back pain caused by vertebrogenic pain.
Medical DevicesRedwood City, US
Alex DiNello(Executive Officer, Director)
BoardRichard Mott(Director)Brent Ahrens(Director)inJason Lettman(Director)John Ryan(Director)
Board seatJustin Klein· per SEC Form D
Co-investorsCanaan PartnersEmergent Medical Partners, LLPLightstone VenturesNew Enterprise Associates (NEA)
Tybrhealth develops the B3 GEL™ System, a protective gel applied during tendon and ligament repair surgery to reduce post-operative scar formation and preserve tissue mobility.
BiotechHealthtechMedical DevicesHouston, US
Tim Keane(Founder)inAlex Smith(Founder)inJeffrey Tyber(Director)Stephen Ramon(Executive Officer)Timothy J. Keane, Jr.(Executive Officer, Director)
BoardToby Hamilton(Director)
Board seatGreg Banker· per SEC Form D
Co-investorsAsymmetry VenturesY CombinatorMutual Capital PartnersVentureSouq
BiotechSan Carlos, US
Surag Mantri(Executive Officer, Director)
BoardMatthew Sprinkel(Director)Amir Abolfathi(Director)Varun Gupta(Director)
Board seatJustin Klein· per SEC Form D
Co-investorsBoutique Venture PartnersLongitude CapitalNeotribe Ventures
Edina, US
BoardThomas Tu(Executive Officer)inWilliam Hoffman(Executive Officer)inSteven Schwen(Executive Officer)in
Board seatMaria BerkmanKirk Nielsen· per SEC Form D · $25M raise · filed Aug 2025
Apella provides an ambient AI platform that connects to the EHR to give hospital surgical teams real-time operating room intelligence, case duration forecasts, and automated documentation.
AI & Machine LearningDigital HealthHealthtech
Co-investorsK2 HealthVenturesLayout VenturesOPAMP CAPITALTwine Ventures
Cleerly is an AI-enabled software platform that analyzes coronary artery disease through advanced imaging analysis, providing clinically actionable insights to support heart attack prevention and personalized patient care.
AI & Machine LearningHealthtechMedical Devices
Co-investorsBreyer CapitalDigiTx Partners LLCLRVHealth
Evident Vascular develops an intravascular ultrasound (IVUS) platform that uses AI for image interpretation and workflow improvements, aimed at peripheral vascular applications.
AI & Machine LearningHealthtechMedical Devices
Danielo Piazza(Founder)Howard Rosen(Founder)
FIRE1 develops NORM, an implantable sensor placed in the inferior vena cava to directly measure fluid volume in heart failure patients, paired with a self-management platform to help patients engage with their own care.
Digital HealthHardwareMedical DevicesDublin, IE
Co-investorsAndera PartnersLightstone VenturesLongitude CapitalNew Enterprise Associates (NEA)
Inari Medical develops mechanical thrombectomy devices for treating venous thromboembolism conditions, including pulmonary embolism, deep vein thrombosis, in-stent thrombosis, and arteriovenous fistula thrombosis.
HardwareHealthtechMedical DevicesIrvine, US
William H. Hoffman(Executive Officer, Director)inRobert Rosenbluth(Executive Officer, Director)
BoardDonald Milder(Director)Kirk Nielsen(Director)inJonathan Root(Director)inBrian Cox(Director)
Co-investorsGilde HealthcareUS Venture PartnersVersant Ventures
BiotechHealthtechWayne, US
Robert Giasolli(Executive Officer)Carol Burns(Executive Officer)Marc Penna(Executive Officer)Monica Klos(Executive Officer)Dennis Wahr(Director)P. Sherrill Neff(Director)
Co-investors415 CapitalH.I.G. CapitalH.I.G. HealthBridge PartnersRunway Growth CapitalH.I.G. BioHealth PartnersNew Enterprise Associates (NEA)
Luna Diabetes builds an automated insulin delivery system for people with diabetes who use insulin pens (MDI) rather than traditional insulin pumps.
Digital HealthHealthtechMedical Devices
Co-investorsInterlock CapitalSerpentine VenturesWinklevoss Capital
Metavention is developing a treatment that targets the sympathetic nervous system to disrupt overactive nerves believed to contribute to high blood pressure and other metabolic diseases.
BiotechHealthtechMedical Devices
Co-investorsSanderling Ventures
St.
HealthtechSt. Louis, US
Scott Wrightstone(Executive Officer)Maureen Oehler(Executive Officer)Jason Pesterfield(Executive Officer, Director)Ryan Denney(Executive Officer)Mark Hunter(Executive Officer)Troy Holsing(Executive Officer)
Co-investorsRC CapitalRex Health Ventures
Co-investorsLightstone Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 3
IPOs and acquisitions across the tracked portfolioCVRxNASDAQ: CVRXSenseonics HoldingsNASDAQ: SENSSpyglass PharmaNASDAQ: SGP
Portfolio news
latest coverage across their companiesSenseonics Holdings · stocktitan.net · Aug 14, 2026
TYBR Health · houston.innovationmap.com · Jul 28, 2026
CVRx · tradersunion.com · Jul 7, 2026
Monteris Medical · winnipegfreepress.com · Mar 19, 2026
Ventaris Surgical · finsmes.com · Jan 12, 2026
Okami Medical · pulse2.com · Dec 1, 2025
Personal Genome Diagnostics · chiefhealthcareexecutive.com · Nov 24, 2025
Luna Diabetes · finsmes.com · Aug 25, 2025
Fund performance · per public LP disclosures
as of Sep 2025| Fund | Vintage | Committed | Net IRR | TVPI | DPI |
|---|---|---|---|---|---|
| Vensana Capital I, L.P.LPs: San Diego City Employees' Retirement System, Richard King Mellon Foundation | 2018 | — | 16.9% | 1.53x | 0.57x |
Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).
Frequently asked questions
- What stage does Vensana Capital invest at?
- Vensana Capital invests at the Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does Vensana Capital focus on?
- Vensana Capital focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Vensana Capital located?
- Vensana Capital is headquartered in Minneapolis, US.
- Does Vensana Capital lead rounds?
- Vensana Capital typically participates in rounds rather than leading them.
Media · Podcasts & interviews
featuring the teamInvestor Forum Testimonial | Justin Klein, MD, JD, Vensana Capital
The MedTech Conference powered by AdvaMed · Justin Klein
Images
Co-investors · 16
New Enterprise Associates (NEA) is a venture capital firm that invests in and provides long-term support to founders building new companies.
Hatteras Venture Partners is a venture capital firm focused on early-stage life sciences and healthcare companies, backing therapeutics, diagnostics, and businesses aiming to transform healthcare delivery and innovation.
Longitude Capital is a healthcare venture capital firm that invests in biotechnology, medical technology, and health solutions companies. The firm focuses on companies working to improve clinical outcomes, quality of life, and healthcare delivery efficiency.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
Northpond Ventures is a venture capital firm based in Bethesda, Maryland that invests in life sciences, technology, and related sectors.
Domain Associates is a venture capital firm founded in 1985 that invests in life sciences companies. The firm operates as a limited liability company.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.
Founders Fund is a venture capital firm that backs technology companies building transformative products.
Highland Capital Partners is a venture capital firm with a 39-year history focused on backing entrepreneurs, reporting 200 exits, over 50 IPOs, 40 unicorns, and $7B in assets under management.
Presight Capital is the international venture fund of entrepreneur Christian Angermayer, operating as a registered investment adviser that can invest across public and private markets with checks from $500K to $100M+ throughout a company's entire lifecycle from seed to post-IPO. The fund is backed by prominent hedge fund managers and billionaire angels rather than traditional institutional investors, and focuses heavily on controversial frontier science like psychedelics, brain-computer interfaces, and life extension alongside transformative infrastructure bets in undercapitalized global markets.
Johnson & Johnson Innovation is the innovation arm of Johnson & Johnson, working to advance life science innovation through early partnerships, incubation via JLABS, venture investing through JJDC, and late-stage partnerships to address global health challenges.
Flagship Pioneering is a firm that creates and builds companies to pioneer breakthroughs in science and technology for people and the planet, active for over 25 years.
▶4 more co-investors
Firms observed investing alongside Vensana Capital, from public investor directories. Shared companies are the overlap with Vensana Capital's recorded portfolio.
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
OneVentures is a later-stage venture capital firm that backs technology and healthcare companies, providing growth equity and credit alongside strategic and operational support.
Abingworth is a life science venture capital firm that backs early-stage biopharma and biotech companies, helping entrepreneurs translate scientific discoveries into new therapeutics.